Petra Rueger

发表

Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle

Anirvan Ghosh, Jens Niewoehner, Petra Rueger, 2014, Neuron.

FcγRIIIa chromatography to enrich a-fucosylated glycoforms and assess the potency of glycoengineered therapeutic antibodies.

Petra Rueger, T. Schlothauer, P. Umaña, 2020, Journal of chromatography. A.

Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies

Apollon Papadimitriou, Tilman Schlothauer, Thomas Emrich, 2013, mAbs.

Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants

J. Buchner, Petra Rueger, Marco Thomann, 2015, PloS one.

Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode.

T. Singer, A. Bujotzek, P. Freskgård, 2018, Cell reports.

Phthalazinone pyrazoles as potent, selective, and orally bioavailable inhibitors of Aurora-A kinase.

R. Engh, G. Georges, Petra Rueger, 2011, Journal of medicinal chemistry.

A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies

Apollon Papadimitriou, Tilman Schlothauer, Thomas Emrich, 2014, mAbs.

Biosensor systems for pesticide determination in water

Ursula Bilitewski, Rolf D. Schmid, Frank F. Bier, 1993, Other Conferences.